Rarely Discussed Topics in Onychomycosis: Antifungal Resistance, Microbiology, and the Evidence for OTC Products Onychomycosis has been a consistent topic at podiatric and dermatology conferences since the first truly effective FDA approved oral antifungal, terbinafine, was approved in the late 1990s. Available On Demand, December 15, 2022
The 2022 Desert Foot Returns to Live-In Person After Virtual COVID Hiatus The 19th Annual Desert Foot Conference Co-Chaired by Drs Charles Andersen, Lawrence Lavery, Matthew Garoufalis, and Thomas Serena led an esteemed faculty of 42 key opinion leaders over four days of knowledge sharing and learning. Conferences, December 12, 2022
Paths to Practice PerfectionTips for Managing VLUs: Decrease Inflammation/Infection, Control Exudate, and Control Edema Clinicians should follow an evidence-based treatment approach for VLUs which includes wound hygiene, exudate management, compression therapy, and appropriate infection/inflammation control. Paths to Practice Perfection, December 9, 2022
Largest Attended Superbones Superwounds West Ever The largest attended Superbones Superwounds West(SBSWW) Conference took place virtually this past weekend in cyberspace, affirming that podiatrists continue to like virtual conferences even after COVID risk has diminished. Conferences, November 2, 2022
